Keywords: Hepatocellular carcinoma (HCC); Percutaneous liver biopsy; Imaging guidance; Diagnostic yield; Efficacy study; AASLD; American Association for the Study of Liver Diseases; CT; Computed Tomography; EASL; European Association for the Study of the Liver; HCC
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: AASLD; American Association for the Study of Liver Diseases; AIH; autoimmune hepatitis; AILDs; autoimmune liver diseases; BMD; bone mineral densitometry; CCA; cholangiocarcinoma; COIs; clinical outcome indicators; CRC; colorectal cancer; DAAs; direct acti
Keywords: CI; confidence interval; CR; complete response; DEE; drug-eluting embolic; EASL; European Association for the Study of the Liver; HCC; hepatocellular carcinoma; mRECIST; modified Response Evaluation Criteria In Solid Tumors; PEG; polyethylene glycol; PR;
Keywords: Autoimmune Liver Diseases; Steroid-Induced Side Effects; Second-Line Treatment; Bone Density; AASLD; American Association of the Study of Liver Diseases; AIH; autoimmune hepatitis; ALT; alanine aminotransferase; DXA; dual-energy X-ray absorptiometry; EASL
Keywords: AASLD; American association for the study of liver diseases; ACLF; Acute-on-chronic liver failure; APASL; The Asian Pacific association for the study of the liver; CLD; chronic liver disease; CLIF-C; chronic liver failure consortium; EASL; European Associ
Keywords: ACLF; acute-on chronic liver failure; APASL; Asian Pacific Association for the Study of the Liver; DDLT; deceased donor liver transplantation; EASL; European Association for the Study of the Liver; MELD; model for end stage liver disease; LDLT; living don
Keywords: TACE; Transarterial Chemoembolization; cTACE; conventional Transarterial Chemoembolization; HCC; hepatocellular carcinoma; EASL; European Association for the Study of the Liver Guidelines; qEASL; 3D quantitative European Association for the Study of the L
Keywords: HVPG; hepatic venous pressure gradient; HCC; hepatocellular carcinoma; PHLF; post-hepatectomy liver failure; MELD; Model for End-stage Liver Disease; PH; portal hypertension; EASL; European Association for the Study of the Liver; AASLD; American Associati
Keywords: ICU; intensive care unit; ACLF; acute on chronic liver failure, CLIF, chronic liver failure organ failure; AST; American society of transplantation; ASTS; American society of transplant surgeons; EASL; European association for the study of the liver; AKI;
Keywords: Transarterial therapy; follow-up; hepatic malignancy; survey; IO; Interventional Oncology; IR; Interventional Radiology; LRT; locoregional therapy; SIR; Society of Interventional Radiology; CT; computed tomography; TACE; transarterial chemoembolization; c
Keywords: Cirrhosis; Acute Decompensation; Organ Failures; Prognosis; ACLF; acute on chronic liver failure; CANONIC; CLIF Acute-on-Chronic Liver Failure in Cirrhosis; CLIF; Chronic Liver Failure; EASL; European Association for the Study of the Liver; Fio2; fraction
Keywords: HCC; hepatocellular carcinoma; TACE; transarterial chemoembolization; OS; overall survival; EASL; European Association for the Study of the Liver; mRECIST; modified Response Evaluation Criteria in Solid Tumors; CT; computed tomography; CR; complete respon
Keywords: Liver Transplantation; HCC; Cholabgiocarcinoma; Machine Perfusion; Hepatitis C; AASLD; American Association for the Study of Liver Diseases; BAR; balance of risk; D-MELD; donor age à recipient Model of End-Stage Liver Disease; DCC; distal cholangiocarci
Keywords: HCC; hepatocellular carcinoma; CHB; chronic hepatitis B; PLC; primary liver cancer; HR; hepatic resection; LT; liver transplantation; US; ultrasound; EASL; European Association for the Study of the Liver; EORTC; European Organization for Research and Trea
Keywords: CI; confidence interval; EASL; European Association for the Study of the Liver; HCC; hepatocellular carcinoma; PVT; portal vein thrombosis; TIPS; transjugular intrahepatic portosystemic shunt; TTP; time to progression; 90Y; yttrium-90;
Keywords: WES; whole exome sequencing; PALF; paediatric acute liver failure; US; United States; MDS; mitochondrial DNA depletion syndrome; WD; Wilson disease; EASL; European Association for the Study of the Liver; CT; computerized tomography; MRI; magnetic resonanc
Keywords: AASLD; American Association for the Study of Liver Diseases; ACLF; acute-on-chronic liver failure; ALD; alcoholic liver disease; ALF; acute liver failure; BCAAs; branched-chain amino acids; CFF; Critical Flicker Frequency; CHE; covert HE; CLD; chronic liv
Keywords: Autoimmune Hepatitis; Cholestasis; Overlap; Atypical Phenotypes; AIH; autoimmune hepatitis; ALT; alanine aminotransferase; AMA; antimitochondrial antibody; AP; alkaline phosphatase; EASL; European Association for the Study of the Liver; ERC; endoscopic re
Keywords: BCLC; Barcelona Clinic Liver Cancer; CI; 95% confidence interval; CP; Child-Pugh; CT; computed tomography; EASL; European Association for the Study of the Liver; HCC; hepatocellular carcinoma; LRT; locoregional therapy; MRI; magnetic resonance imaging;
Keywords: mRECIST; EASL; Overall survival; Prediction; Equivalence;
Acute on Chronic Liver Failure-In-Hospital Predictors of Mortality in ICU
Keywords: ACLF; acute on chronic liver failure; APASL; Asia-Pacific Association for Study of Liver Disease; EASL; European Association for Study of Liver Disease; acute on chronic liver failure; intensive care unit; predictors; mortality; CLIF-SOFA;
Impact of Direct Acting Antiviral Therapy for Treatment of Hepatitis C Genotypes 1, 3 and 4: A Real Life Experience from India
Keywords: DAA; Direct Acting Antiviral; DCV; Daclatasvir; EASL; European Association of Study of the Liver (EASL); ETR; End of Treatment Response; HBV; Hepatitis B; HCC; Hepatocellular Carcinoma; HCV; Hepatitis C Virus; HIV; Human Immunedeficiency Virus; ITT; inten
Consenso Mexicano para el Tratamiento de la Hepatitis C
Keywords: Consenso; Agentes antivirales de acción directa; RegÃmenes libres de interferón; Ribavirina; Consensus; Direct-acting antiviral agents; Interferon-free regimens; Ribavirin; AAD; antivirales de acción directa; AASLD; Asociación Americana para el Estud
The Mexican consensus on the treatment of hepatitis C
Keywords: Consensus; Direct-acting antiviral agents; Interferon-free regimens; Ribavirin; Consenso; Agentes antivirales de acción directa; RegÃmenes libres de interferón; Ribavirina; AASLD; American Association for the Study of Liver Diseases; AFP; alpha-fetopro
INASL Position Statements on Prevention, Diagnosis and Management of Hepatitis B Virus Infection in India: The Andaman Statements
Keywords: AASLD; American Association for the Study of Liver Diseases; ADV; adefovir dipivoxil; ALT; alanine aminotransferase; Anti-HBe; antibodies to hepatitis B envelope antigen; anti-HBs; antibody to hepatitis B surface antigen; APASL; Asian Pacific Association
Restrictions on access to direct-acting antivirals for people who inject drugs: The European Hep-CORE study and the role of patient groups in monitoring national HCV responses
Keywords: DAA; direct-acting antiviral; EASL; European Association for the Study of the Liver; EFTA; European Free Trade Association; ELPA; European Liver Patients' Association; EU; European Union; HCV; hepatitis C virus; HIV; human immunodeficiency virus; PWID;
Evaluation of response after SBRT for liver tumors
Keywords: SBRT; stereotactic body radiotherapy; RECIST; criteria of response in solid tumors; mRECIST; modified criteria of response in solid tumors; CT; computerized tomography; MRI; magnetic resonance imaging; PET; positron-emission tomography; HCC; Hepatocellula
Transarterial Chemoembolization with Small Drug-Eluting Beads in Patients with Hepatocellular Carcinoma: Experience from a Cohort of 421 Patients at an Italian Center
Keywords: BCLC; Barcelona Clinic Liver Cancer; CI; confidence interval; DEE; drug-eluting embolic; EASL; European Association for the Study of the Liver; HCC; hepatocellular carcinoma; mRECIST; modified Response Evaluation Criteria In Solid Tumors; ORR; overall res
Validation of Clinical Scoring Systems ART and ABCR after Transarterial Chemoembolization of Hepatocellular Carcinoma
Keywords: ABCR; α-fetoprotein, Barcelona Clinic Liver Cancer, Child-Pugh, and response [score]; AFP; α-fetoprotein; ART; Assessment for Retreatment with Transarterial Chemoembolization [score]; BCLC; Barcelona Clinic Liver Cancer; CI; confidence interval; EASL;
Chronic Hepatitis C: Do Generics Work as Well as Branded Drugs?
Keywords: ALT; alanine aminotransferase; CHC; chronic hepatitis C; CI; confidence interval; DAAs; direct-acting antiviral agents; DCV; daclatasvir; EASL; The European Association for the Study of the Liver; GT; Genotype; HCC; hepatocellular carcinoma; HCV; hepatiti
Modified Response Evaluation Criteria in Solid Tumors and European Association for the Study of the Liver Criteria Using Delayed-Phase Imaging at an Early Time Point Predict Survival in Patients with Unresectable Intrahepatic Cholangiocarcinoma following
Keywords: CR; complete response; EASL; European Association for the Study of the Liver; ICC; intrahepatic cholangiocarcinoma; mRECIST; modified Response Evaluation Criteria In Solid Tumors; PD; progressive disease; PR; partial response; RECIST; Response Evaluation
Research PaperDifferentiation between cholangiocarcinoma and hepatocellular carcinoma with target sign on diffusion-weighted imaging and hepatobiliary phase gadoxetic acid-enhanced MR imaging: Classification tree analysis applying capsule and septum
Keywords: CTA; classification tree analysis; HCC; hepatocellular carcinoma; HBP; hepatobiliary phase; DWI; diffusion-weighted imaging; ICC; intrahepatic cholangiocarcinoma; EASL; European Association for the Study of the Liver; AASLD; American Association for the S
Radioembolization of Hepatic Malignancies: Background, Quality Improvement Guidelines, and Future Directions
Keywords: AFP; α-fetoprotein; ECOG; Eastern Cooperative Oncology Group; EASL; European Association for Study of the Liver; FDA; Food and Drug Administration; FDG; fluorodeoxyglucose; HCC; hepatocellular carcinoma; MAA; macroaggregated albumin; mRECIST; modified Re
Clinical challengeChronic hepatitis B and fatty liver: Issues in clinical management
Keywords: ALT; Alanine aminotransferase; CHB; chronic hepatitis B; AASLD; American association for study of liver disease; APASL; Asia-pacific association for study of liver; EASL; European association for study of liver; HCC; hepatocellular carcinoma; HBeAg; hepat
Transient elastography in autoimmune hepatitis: Timing determines the impact of inflammation and fibrosis
Keywords: AIH; autoimmune hepatitis; ALT; alanine aminotransferase; ANA; antinuclear antibody; AUROC; area under the receiver operating curve; EASL; European Association for the Study of the Liver; IgG; immunoglobulin G; LS; liver stiffness; NPV; negative predictiv
Research ArticleModelling the impact of deferring HCV treatment on liver-related complications in HIV coinfected men who have sex with men
Keywords: HCV; Hepatitis C virus; PWLH; People who live with HIV; MSM; Men who have sex with men; DC; Decompensated cirrhosis; HCC; Hepatocellular carcinoma; PegIFN; Pegylated-interferon-α; RBV; Ribavirin; DAA; Direct acting antivirals; EASL; European Association
Comparison of Choi criteria and Response Evaluation Criteria in Solid Tumors (RECIST) for intrahepatic cholangiocarcinoma treated with glass-microspheres Yttrium-90 selective internal radiation therapy (SIRT)
Keywords: CI; confidence interval; EASL; European Association for the Study of Liver; ICC; intrahepatic cholangiocarcinoma; OR; objective response; OS; overall survival; RECIST; Response Evaluation Criteria in Solid Tumors; SIRT; Yttrium-90 glass microspheres selec
Research ArticleDiagnostic criteria for hepatocellular carcinoma ⩽3 cm with hepatocyte-specific contrast-enhanced magnetic resonance imaging
Keywords: HCC; hepatocellular carcinoma; CT; computed tomography; MRI; magnetic resonace imaging; RFA; radiofrequency ablation; EASL; European Association for the Study of the Liver; AASLD; American Association for the Study of Liver Disease; BCLC; Barcelona Clinic
Single- versus Triple-Drug Chemoembolization for Hepatocellular Carcinoma: Comparing Outcomes by Toxicity, Imaging Response, and Survival
Keywords: BCLC; Barcelona Clinic for Liver Cancer; CI; confidence interval; EASL; European Association for the Study of the Liver; ECOG; Eastern Cooperative Oncology Group; HCC; hepatocellular carcinoma; OS; overall survival; PVT; portal vein thrombosis; TTP; time
Diffusion-Weighted MR Imaging of Hepatocellular Carcinoma: Current Value in Clinical Evaluation of Tumor Response to Locoregional Treatment
Keywords: ADC; apparent diffusion coefficient; DWI; diffusion-weighted imaging; EASL; European Association for the Study of the Liver; EPI; echoplanar imaging; HCC; hepatocellular carcinoma; LRT; locoregional therapy; mRECIST; modified Response Evaluation Criteria
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
Keywords: ALT; alanine transaminase; BMI; body mass index; CAP; controlled attenuation parameter; CCR; chemokine receptor; CK-18; cytokeratin-18 fragments; CKD; chronic kidney disease; CT; computed tomography; CVD; cardiovascular disease; EASD; European Association
Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma
Keywords: Randomized Trial; Chemoembolization; Radioembolization; Liver Cancer; BCLC; Barcelona Clinic Liver Cancer; CI; confidence interval; CT; computed tomography; cTACE; conventional transarterial chemoembolization; EASL; European Association for the Study of t
Management of mother-to-child transmission of hepatitis B virus: Propositions and challenges
Keywords: HBV; hepatitis B virus; HBI; Ghepatitis B immunoglobulin; MTCT; mother to child transmission; HCC; hepatocellular carcinoma; HBIG; hepatitis B immunoglobulin; HBsAg; hepatitis Bs antigen; HBeAg; hepatitis Be antigen; WHO; World Health Organization; PBMC;
HBV DNA Integration and Clonal Hepatocyte Expansion in Chronic Hepatitis B Patients Considered Immune Tolerant
Keywords: HBsAg; Antiviral Immunity; HBV Replication; Hepatocyte Proliferation; AASLD; American Association for the Study of Liver Diseases; ALT; alanine aminotransferase; cccDNA; covalently closed circular DNA; CHB; chronic hepatitis B; EASL; European Association
Transarterial chemoembolization in soft-tissue sarcoma metastases to the liver - The use of imaging biomarkers as predictors of patient survival
Keywords: Liver cancer; Sarcoma; Transarterial chemoembolization; Volumetry; MRI; RECIST; mRECIST; EASL; mSTS; metastatic soft-tissue sarcoma; qEASL; quantitative European Association for the Study of the Liver; RECIST; Response Evaluation Criteria in Solid Tumors;
Liver, Pancreas and Biliary TractInter-observer variability of response evaluation criteria for hepatocellular carcinoma treated with chemoembolization
Keywords: EASL; Hepatocellular carcinoma; Inter-observer variability; mRECIST; Treatment response;
Baseline and Early MR Apparent Diffusion Coefficient Quantification as a Predictor of Response of Unresectable Hepatocellular Carcinoma to Doxorubicin Drug-Eluting Bead Chemoembolization
Keywords: ADC; apparent diffusion coefficient; AUC; area under the curve; CR; complete response; DEB; drug-eluting bead; DWI; diffusion-weighted imaging; EASL; European Association for the Study of the Liver; HCC; hepatocellular carcinoma; LRT; locoregional therapy
Outcomes of Patients With Chronic Hepatitis B Who Do Not Meet Criteria for Antiviral Treatment at Presentation
Keywords: Antiviral Agent; Cancer; HBV Infection; Management; AASLD; American Association for the Study of Liver Disease; ALT; alanine aminotransferase; APASL; Asian Pacific Association for the Study of the Liver; CHB; chronic hepatitis B; EASL; European Associatio
Research ArticleClinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma
Keywords: HCC; hepatocellular carcinoma; EASL; European Association for the Study of the Liver; AASLD; American Association for the Study of Liver Diseases; CT; computed tomography; MRI; magnetic resonance imaging; FNB; fine needle biopsy; CEUS; contrast enhanced u
Management of Hepatitis B: Our Practice and How It Relates to the Guidelines
Keywords: Chronic Hepatitis B; Management; Antiviral Therapy; Hepatitis B Guidelines; AASLD; American Association for the Study of Liver Diseases; AFP; α-fetoprotein; ALT; alanine aminotransferase; anti-HBc; hepatitis B core antibody; anti-HBe; hepatitis B e antib